Cosciens Biopharma Stock Price Prediction
| CSCI Stock | 2.92 0.21 6.71% |
Oversold Vs Overbought
38
Oversold | Overbought |
Quarterly Revenue Growth 0.041 |
Using COSCIENS Biopharma hype-based prediction, you can estimate the value of COSCIENS Biopharma from the perspective of COSCIENS Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in COSCIENS Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying COSCIENS because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
COSCIENS Biopharma after-hype prediction price | USD 2.95 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
COSCIENS |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of COSCIENS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
COSCIENS Biopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of COSCIENS Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in COSCIENS Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of COSCIENS Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
COSCIENS Biopharma Estimiated After-Hype Price Volatility
In the context of predicting COSCIENS Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on COSCIENS Biopharma's historical news coverage. COSCIENS Biopharma's after-hype downside and upside margins for the prediction period are 0.15 and 5.91, respectively. We have considered COSCIENS Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
COSCIENS Biopharma is unstable at this time. Analysis and calculation of next after-hype price of COSCIENS Biopharma is based on 3 months time horizon.
COSCIENS Biopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as COSCIENS Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading COSCIENS Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with COSCIENS Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 2.96 | 0.03 | 0.03 | 4 Events / Month | 3 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.92 | 2.95 | 1.03 |
|
COSCIENS Biopharma Hype Timeline
COSCIENS Biopharma is currently traded for 2.92. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -0.03. COSCIENS is forecasted to increase in value after the next headline, with the price projected to jump to 2.95 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 1.03%, whereas the daily expected return is currently at -0.33%. The volatility of related hype on COSCIENS Biopharma is about 3075.32%, with the expected price after the next announcement by competition of 2.89. The company reported the previous year's revenue of 7.26 M. Net Loss for the year was (3.55 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out COSCIENS Biopharma Basic Forecasting Models to cross-verify your projections.COSCIENS Biopharma Related Hype Analysis
Having access to credible news sources related to COSCIENS Biopharma's direct competition is more important than ever and may enhance your ability to predict COSCIENS Biopharma's future price movements. Getting to know how COSCIENS Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how COSCIENS Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BOC | Boston Omaha Corp | 0.1 | 11 per month | 1.56 | (0.01) | 1.91 | (2.39) | 8.78 | |
| KDP | Keurig Dr Pepper | (0.21) | 10 per month | 0.00 | (0.23) | 1.46 | (2.08) | 6.67 | |
| TBVPY | Thai Beverage PCL | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WIMI | WiMi Hologram Cloud | 0.02 | 6 per month | 4.13 | 0.02 | 8.42 | (6.33) | 26.90 | |
| CSXXY | CarsalesCom Ltd ADR | 0.00 | 0 per month | 1.68 | 0.01 | 6.22 | (5.22) | 16.82 | |
| COCO | Vita Coco | (0.91) | 11 per month | 1.47 | 0.18 | 3.72 | (3.13) | 11.39 | |
| SNDL | SNDL Inc | 0.23 | 8 per month | 3.01 | (0.03) | 3.86 | (3.62) | 24.46 | |
| STBFY | Suntory Beverage Food | 0.00 | 0 per month | 0.00 | (0.15) | 1.93 | (2.71) | 5.47 |
COSCIENS Biopharma Additional Predictive Modules
Most predictive techniques to examine COSCIENS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for COSCIENS using various technical indicators. When you analyze COSCIENS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About COSCIENS Biopharma Predictive Indicators
The successful prediction of COSCIENS Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as COSCIENS Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of COSCIENS Biopharma based on analysis of COSCIENS Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to COSCIENS Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to COSCIENS Biopharma's related companies.
Story Coverage note for COSCIENS Biopharma
The number of cover stories for COSCIENS Biopharma depends on current market conditions and COSCIENS Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that COSCIENS Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about COSCIENS Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
COSCIENS Biopharma Short Properties
COSCIENS Biopharma's future price predictability will typically decrease when COSCIENS Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of COSCIENS Biopharma often depends not only on the future outlook of the potential COSCIENS Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. COSCIENS Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.3 M |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |